A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathyHannah Imlay, Ajit P. Limaye, James Rooney et al.|Transplant Infectious Disease|2024Cited by 5